About Us

Alzamend Neuro^®, Inc., (“Alzamend^®”), a Delaware corporation with its headquarters in Tampa, Florida with nexus in California, is an early clinical-stage, biopharmaceutical company. At Alzamend, we are committed to “Making Alzheimer’s Just a Memory™.” Our mission is to help the Alzheimer’s community by supporting the full product development life cycle of pharmaceutical, biologic, and immunological products for the treatment and cures for Alzheimer’s Disease (“AD”). We are driven by the belief that strong support of research is the foundation for true innovation and uniquely position us to understand and effectively address the unmet needs of the patients we serve. Alzamend strives to provide hope through the commercialization of existing patented intellectual properties and know-how while simultaneously funding future treatments for other neurodegenerative diseases and psychiatric disorders, through advanced research and development.